This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: DE, CAT, ADM, NKE, OPEN

>>Countdown to our free event: Meet the Real Money Pros: Market Strategies for 2012


Abercrombie & Fitch (ANF - Get Report) cut from Conviction Buy List at Goldman. Valuation call, as the stock is up 32% over the past 11 months.

Aeropostale (ARO) upgraded at Goldman from Sell to Neutral. The company can expand margins in the coming quarter.

Amedisys (AMED) downgraded to sell at TheStreet Ratings.

American Tower (AMT) numbers adjusted at Citigroup. Shares of AMT now seen reaching $65. Estimates lowered on FX headwinds. Buy rating.

American Tower estimates, target raised at JP Morgan. Shares of AMT now seen reaching $62. Estimates also increased on Core and Sprint MLA.

AmerisourceBergen (ABC) estimates increased at UBS. ABC estimates increased through 2013. Positive operating trends. Maintain $47 price target and Buy rating.

Ann (ANN) downgraded at Goldman from Neutral to Sell. Margins are peaking and the company is leveraged to slower macro growth.

Archer Daniels Midland (ADM - Get Report) numbers cut at Morgan Stanley. Shares of ADM now seen reaching $37. Estimates also reduced, given lower oilseed margins. Overweight rating.

Atmel (ATML) downgraded at Needham from Strong Buy to Buy. Company could face inventory rebalancing in the next couple of quarters.

Atmel upgraded to buy at TheStreet Ratings.

Autodesk (ADSK) target cut at UBS to $43. VARs continue to plod through a sluggish economic environment. Buy rating.

Baker Hughes (BHI - Get Report) numbers cut at Credit Suisse. Shares of BHI now seen reaching $80. Estimates also reduced, given lower expected North American pricing. Outperform rating.

Baker Hughes estimates increased at Sterne Agee. BHI estimates raised through 2012. Bullish rig count forecast. Maintain $71 price target and Buy rating.

Baker Hughes estimates, target cut at UBS. Shares of BHI now seen reaching $82. Estimates also increased as overall story is still in on track despite a sloppy 3Q. Buy rating.

Catalyst Health (CHSI) numbers lowered at Credit Suisse. Shares of CHSI now seen reaching $62. Estimates also cut, to match the company's new guidance. Outperform rating.

Caterpillar (CAT - Get Report) rated new Overweight at Morgan Stanley. Valuation call, based on a $125 price target.

CME Group (CME - Get Report) numbers lowered at Jefferies. CME estimates were cut through 2012. Volume has moderates and expenses could be back on the rise. Buy rating and new $297 price target.

CME Group estimates lowered at UBS through 2012. MF Global bankruptcy may be a blow to the futures industry as a whole. Buy rating.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ADM $33.58 0.84%
ANF $24.13 -2.03%
BHI $41.75 -2.50%
CAT $63.93 -1.01%
CME $93.31 3.46%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs